Cargando…

Biological Markers Predictive of Invasive Recurrence in DCIS

DCIS is a heterogeneous group of non-invasive cancers of the breast characterized by various degrees of differentiation and unpredictable propensity for transformation into invasive carcinoma. We examined the expression and prognostic value of 9 biological markers with a potential role in tumor prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nofech-Mozes, Sharon, Spayne, Jacqueline, Rakovitch, Eileen, Kahn, Harriette J, Seth, Arun, Pignol, Jean-Phillippe, Lickley, Lavina, Paszat, Lawrence, Hanna, Wedad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2008
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161685/ https://www.ncbi.nlm.nih.gov/pubmed/21892261

Ejemplares similares

Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
por: Hahn, Ezra, et al.
Publicado: (2023)

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
por: Rakovitch, E, et al.
Publicado: (2012)

Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis
por: Klein, Jonathan, et al.
Publicado: (2015)

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
por: Rakovitch, E., et al.
Publicado: (2018)

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
por: Rakovitch, Eileen, et al.
Publicado: (2015)

Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) Score
por: Lalani, Nafisha, et al.
Publicado: (2017)

Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma In Situ (DCIS) of the Breast
por: Axelrod, David E., et al.
Publicado: (2008)

Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast
por: Miller, Naomi A., et al.
Publicado: (2010)

Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment
por: Chapman, Judith-Anne W, et al.
Publicado: (2007)

Microcalcification crystallography as a potential marker of DCIS recurrence
por: Gosling, Sarah B., et al.
Publicado: (2023)

Intraoperative Assessment of Sentinel Lymph Nodes in Breast Cancer Patients Post-Neoadjuvant Therapy
por: Wong, Willard, et al.
Publicado: (2019)

Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
por: Lari, Sara A., et al.
Publicado: (2011)

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
por: Wallis, M G, et al.
Publicado: (2012)

61. EXPRESSION OF ANDROGEN RECEPTOR IN BREAST CANCER BRAIN METASTASIS
por: Qazi, Maleeha, et al.
Publicado: (2020)

MLH1 Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal
por: Plotkin, Anna, et al.
Publicado: (2023)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
por: Pinder, S E, et al.
Publicado: (2010)

A Cluster-then-label Semi-supervised Learning Approach for Pathology Image Classification
por: Peikari, Mohammad, et al.
Publicado: (2018)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Ductal carcinoma in situ (DCIS): the role of prognostic indicators in informing treatment and reducing local recurrence
por: Clements, K, et al.
Publicado: (2004)

Retroperitoneal Extraovarian Fibrothecoma Mimicking a Malignant Epithelial Ovarian Carcinoma
por: Roberts, Patrick, et al.
Publicado: (2012)

EMT in Breast Carcinoma—A Review
por: Felipe Lima, Joema, et al.
Publicado: (2016)

Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators
por: Spayne, Jacqueline, et al.
Publicado: (2021)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Imaging features of noncalcified DCIS
por: Scudder, JM, et al.
Publicado: (2012)

Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI
por: Park, Ga Eun, et al.
Publicado: (2022)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2(+):ERα(-) breast cancer
por: Liu, Jeffrey C., et al.
Publicado: (2017)

HER2-LOW BREAST CANCER BRAIN METASTASES: INCIDENCE AND TREATMENT IMPLICATIONS
por: Chehade, Rania, et al.
Publicado: (2023)

Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases
por: Corradini, Stefanie, et al.
Publicado: (2018)

Boost und Hypofraktionierung beim DCIS
por: Dunst, Jürgen, et al.
Publicado: (2022)

Pan-cancer classification of single cells in the tumour microenvironment
por: Nofech-Mozes, Ido, et al.
Publicado: (2023)

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
por: Barnes, N, et al.
Publicado: (2006)

Overall survival is improved when DCIS accompanies invasive breast cancer
por: Kole, Adam J., et al.
Publicado: (2019)

Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment
por: Akbar, Shazia, et al.
Publicado: (2019)

Overcoming the limitations of patch-based learning to detect cancer in whole slide images
por: Ciga, Ozan, et al.
Publicado: (2021)

Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent
por: Fan, Kevin Yijun, et al.
Publicado: (2023)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_rufa19kdgn0lk2d6kmebfdv19n